TECHNIVIE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Technivie, and what generic alternatives are available?
Technivie is a drug marketed by Abbvie and is included in one NDA. There are eight patents protecting this drug.
This drug has four hundred and forty-nine patent family members in forty-eight countries.
The generic ingredient in TECHNIVIE is ombitasvir; paritaprevir; ritonavir. Additional details are available on the ombitasvir; paritaprevir; ritonavir profile page.
DrugPatentWatch® Generic Entry Outlook for Technivie
Technivie was eligible for patent challenges on December 19, 2018.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be April 13, 2032. This may change due to patent challenges or generic licensing.
There have been eight patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
Indicators of Generic Entry
Summary for TECHNIVIE
International Patents: | 449 |
US Patents: | 8 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TECHNIVIE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TECHNIVIE |
DailyMed Link: | TECHNIVIE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TECHNIVIE
Generic Entry Date for TECHNIVIE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for TECHNIVIE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AbbVie | Phase 3 |
AbbVie | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TECHNIVIE
US Patents and Regulatory Information for TECHNIVIE
TECHNIVIE is protected by eight US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of TECHNIVIE is ⤷ Try a Trial.
This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting TECHNIVIE
Solid pharmaceutical dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Solid pharmaceutical dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Macrocyclic hepatitis C serine protease inhibitors
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Macrocyclic hepatitis C serine protease inhibitors
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF HCV INFECTION USING PARITAPREVIR
Solid compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Anti-viral compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Anti-viral compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF HCV INFECTION USING OMBITASVIR
Compositions and methods for treating HCV
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF HCV INFECTION USING PARITAPREVIR
Expired US Patents for TECHNIVIE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for TECHNIVIE
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
AbbVie Deutschland GmbH Co. KG | Viekirax | ombitasvir, paritaprevir, ritonavir | EMEA/H/C/003839 Viekirax is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.For hepatitis C virus (HCV) genotype specific activity. |
Authorised | no | no | no | 2015-01-14 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for TECHNIVIE
When does loss-of-exclusivity occur for TECHNIVIE?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 7060
Estimated Expiration: ⤷ Try a Trial
Patent: 3240
Estimated Expiration: ⤷ Try a Trial
Patent: 3398
Estimated Expiration: ⤷ Try a Trial
Patent: 2505
Estimated Expiration: ⤷ Try a Trial
Patent: 4816
Estimated Expiration: ⤷ Try a Trial
Australia
Patent: 10258769
Estimated Expiration: ⤷ Try a Trial
Patent: 11264823
Estimated Expiration: ⤷ Try a Trial
Patent: 11316506
Estimated Expiration: ⤷ Try a Trial
Brazil
Patent: 1004894
Estimated Expiration: ⤷ Try a Trial
Patent: 2012031500
Estimated Expiration: ⤷ Try a Trial
Patent: 2013005701
Estimated Expiration: ⤷ Try a Trial
Patent: 2012031500
Estimated Expiration: ⤷ Try a Trial
Canada
Patent: 37601
Estimated Expiration: ⤷ Try a Trial
Patent: 02180
Estimated Expiration: ⤷ Try a Trial
Patent: 07847
Estimated Expiration: ⤷ Try a Trial
Patent: 19894
Estimated Expiration: ⤷ Try a Trial
Patent: 28495
Estimated Expiration: ⤷ Try a Trial
Patent: 47910
Estimated Expiration: ⤷ Try a Trial
Patent: 38547
Estimated Expiration: ⤷ Try a Trial
Patent: 97170
Estimated Expiration: ⤷ Try a Trial
Chile
Patent: 11000689
Estimated Expiration: ⤷ Try a Trial
Patent: 12003470
Estimated Expiration: ⤷ Try a Trial
Patent: 13000970
Estimated Expiration: ⤷ Try a Trial
Patent: 13002299
Estimated Expiration: ⤷ Try a Trial
Patent: 14000059
Estimated Expiration: ⤷ Try a Trial
China
Patent: 2333772
Estimated Expiration: ⤷ Try a Trial
Patent: 3153988
Estimated Expiration: ⤷ Try a Trial
Patent: 3172620
Estimated Expiration: ⤷ Try a Trial
Patent: 3209686
Estimated Expiration: ⤷ Try a Trial
Patent: 3354808
Estimated Expiration: ⤷ Try a Trial
Patent: 3596941
Estimated Expiration: ⤷ Try a Trial
Patent: 3819459
Estimated Expiration: ⤷ Try a Trial
Patent: 3819537
Estimated Expiration: ⤷ Try a Trial
Patent: 4193729
Estimated Expiration: ⤷ Try a Trial
Patent: 6986861
Estimated Expiration: ⤷ Try a Trial
Patent: 8350016
Estimated Expiration: ⤷ Try a Trial
Colombia
Patent: 40538
Estimated Expiration: ⤷ Try a Trial
Patent: 60490
Estimated Expiration: ⤷ Try a Trial
Patent: 61348
Estimated Expiration: ⤷ Try a Trial
Costa Rica
Patent: 120650
Estimated Expiration: ⤷ Try a Trial
Patent: 130170
Estimated Expiration: ⤷ Try a Trial
Patent: 140021
Estimated Expiration: ⤷ Try a Trial
Croatia
Patent: 0130671
Estimated Expiration: ⤷ Try a Trial
Patent: 0150017
Estimated Expiration: ⤷ Try a Trial
Patent: 0150926
Estimated Expiration: ⤷ Try a Trial
Patent: 0151389
Estimated Expiration: ⤷ Try a Trial
Patent: 0160408
Estimated Expiration: ⤷ Try a Trial
Patent: 0181658
Estimated Expiration: ⤷ Try a Trial
Cyprus
Patent: 14356
Estimated Expiration: ⤷ Try a Trial
Patent: 16060
Estimated Expiration: ⤷ Try a Trial
Patent: 16748
Estimated Expiration: ⤷ Try a Trial
Patent: 17188
Estimated Expiration: ⤷ Try a Trial
Patent: 17456
Estimated Expiration: ⤷ Try a Trial
Denmark
Patent: 68890
Estimated Expiration: ⤷ Try a Trial
Patent: 55376
Estimated Expiration: ⤷ Try a Trial
Patent: 79854
Estimated Expiration: ⤷ Try a Trial
Patent: 28481
Estimated Expiration: ⤷ Try a Trial
Patent: 92346
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
Dominican Republic
Patent: 011000087
Estimated Expiration: ⤷ Try a Trial
Patent: 012000307
Estimated Expiration: ⤷ Try a Trial
Patent: 013000078
Estimated Expiration: ⤷ Try a Trial
Patent: 013000185
Estimated Expiration: ⤷ Try a Trial
Ecuador
Patent: 11010937
Estimated Expiration: ⤷ Try a Trial
Patent: 13010937
Estimated Expiration: ⤷ Try a Trial
Patent: 13012382
Estimated Expiration: ⤷ Try a Trial
Patent: 13012622
Estimated Expiration: ⤷ Try a Trial
Patent: 14012622
Estimated Expiration: ⤷ Try a Trial
Patent: 17064986
Estimated Expiration: ⤷ Try a Trial
Eurasian Patent Organization
Patent: 0031
Estimated Expiration: ⤷ Try a Trial
Patent: 3570
Estimated Expiration: ⤷ Try a Trial
Patent: 4100
Estimated Expiration: ⤷ Try a Trial
Patent: 4538
Estimated Expiration: ⤷ Try a Trial
Patent: 6848
Estimated Expiration: ⤷ Try a Trial
Patent: 3332
Estimated Expiration: ⤷ Try a Trial
Patent: 1170401
Estimated Expiration: ⤷ Try a Trial
Patent: 1291394
Estimated Expiration: ⤷ Try a Trial
Patent: 1300495
Estimated Expiration: ⤷ Try a Trial
Patent: 1301158
Estimated Expiration: ⤷ Try a Trial
Patent: 1390538
Estimated Expiration: ⤷ Try a Trial
Patent: 1400115
Estimated Expiration: ⤷ Try a Trial
European Patent Office
Patent: 37781
Estimated Expiration: ⤷ Try a Trial
Patent: 68890
Estimated Expiration: ⤷ Try a Trial
Patent: 55376
Estimated Expiration: ⤷ Try a Trial
Patent: 79854
Estimated Expiration: ⤷ Try a Trial
Patent: 27651
Estimated Expiration: ⤷ Try a Trial
Patent: 28481
Estimated Expiration: ⤷ Try a Trial
Patent: 51885
Estimated Expiration: ⤷ Try a Trial
Patent: 78334
Estimated Expiration: ⤷ Try a Trial
Patent: 92346
Estimated Expiration: ⤷ Try a Trial
Patent: 92726
Estimated Expiration: ⤷ Try a Trial
Patent: 53531
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
Patent: 44642
Estimated Expiration: ⤷ Try a Trial
Patent: 38106
Estimated Expiration: ⤷ Try a Trial
Patent: 56318
Estimated Expiration: ⤷ Try a Trial
Guatemala
Patent: 1100074
Estimated Expiration: ⤷ Try a Trial
Patent: 1200332
Estimated Expiration: ⤷ Try a Trial
Patent: 1300093
Estimated Expiration: ⤷ Try a Trial
Patent: 1300093A
Estimated Expiration: ⤷ Try a Trial
Hong Kong
Patent: 52620
Estimated Expiration: ⤷ Try a Trial
Patent: 61245
Estimated Expiration: ⤷ Try a Trial
Patent: 70739
Estimated Expiration: ⤷ Try a Trial
Patent: 84068
Estimated Expiration: ⤷ Try a Trial
Patent: 86415
Estimated Expiration: ⤷ Try a Trial
Patent: 88717
Estimated Expiration: ⤷ Try a Trial
Hungary
Patent: 25758
Estimated Expiration: ⤷ Try a Trial
Patent: 26832
Estimated Expiration: ⤷ Try a Trial
Patent: 28825
Estimated Expiration: ⤷ Try a Trial
Patent: 39719
Estimated Expiration: ⤷ Try a Trial
Patent: 500019
Estimated Expiration: ⤷ Try a Trial
Patent: 700040
Estimated Expiration: ⤷ Try a Trial
Israel
Patent: 1792
Estimated Expiration: ⤷ Try a Trial
Patent: 3535
Estimated Expiration: ⤷ Try a Trial
Patent: 5010
Estimated Expiration: ⤷ Try a Trial
Patent: 9248
Estimated Expiration: ⤷ Try a Trial
Patent: 3857
Estimated Expiration: ⤷ Try a Trial
Patent: 4781
Estimated Expiration: ⤷ Try a Trial
Patent: 1206
Estimated Expiration: ⤷ Try a Trial
Japan
Patent: 30514
Estimated Expiration: ⤷ Try a Trial
Patent: 14356
Estimated Expiration: ⤷ Try a Trial
Patent: 34085
Estimated Expiration: ⤷ Try a Trial
Patent: 06253
Estimated Expiration: ⤷ Try a Trial
Patent: 11838
Estimated Expiration: ⤷ Try a Trial
Patent: 22699
Estimated Expiration: ⤷ Try a Trial
Patent: 59830
Estimated Expiration: ⤷ Try a Trial
Patent: 59736
Estimated Expiration: ⤷ Try a Trial
Patent: 86147
Estimated Expiration: ⤷ Try a Trial
Patent: 43135
Estimated Expiration: ⤷ Try a Trial
Patent: 90202
Estimated Expiration: ⤷ Try a Trial
Patent: 12529534
Estimated Expiration: ⤷ Try a Trial
Patent: 13528225
Estimated Expiration: ⤷ Try a Trial
Patent: 13539791
Estimated Expiration: ⤷ Try a Trial
Patent: 14065710
Estimated Expiration: ⤷ Try a Trial
Patent: 14144973
Estimated Expiration: ⤷ Try a Trial
Patent: 14504296
Estimated Expiration: ⤷ Try a Trial
Patent: 14510063
Estimated Expiration: ⤷ Try a Trial
Patent: 16106075
Estimated Expiration: ⤷ Try a Trial
Patent: 16128456
Estimated Expiration: ⤷ Try a Trial
Patent: 17171680
Estimated Expiration: ⤷ Try a Trial
Patent: 18065828
Estimated Expiration: ⤷ Try a Trial
Patent: 18529671
Estimated Expiration: ⤷ Try a Trial
Patent: 19194254
Estimated Expiration: ⤷ Try a Trial
Patent: 20059696
Estimated Expiration: ⤷ Try a Trial
Patent: 21035964
Estimated Expiration: ⤷ Try a Trial
Lithuania
Patent: 368890
Estimated Expiration: ⤷ Try a Trial
Patent: 692346
Estimated Expiration: ⤷ Try a Trial
Patent: 2017033
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
Luxembourg
Patent: 0038
Estimated Expiration: ⤷ Try a Trial
Patent: 668
Estimated Expiration: ⤷ Try a Trial
Malaysia
Patent: 4064
Estimated Expiration: ⤷ Try a Trial
Patent: 4607
Estimated Expiration: ⤷ Try a Trial
Patent: 6633
Estimated Expiration: ⤷ Try a Trial
Mexico
Patent: 9989
Estimated Expiration: ⤷ Try a Trial
Patent: 4092
Estimated Expiration: ⤷ Try a Trial
Patent: 6264
Estimated Expiration: ⤷ Try a Trial
Patent: 11005673
Estimated Expiration: ⤷ Try a Trial
Patent: 12014384
Estimated Expiration: ⤷ Try a Trial
Patent: 13004150
Estimated Expiration: ⤷ Try a Trial
Patent: 13006951
Estimated Expiration: ⤷ Try a Trial
Patent: 13009763
Estimated Expiration: ⤷ Try a Trial
Patent: 18002707
Estimated Expiration: ⤷ Try a Trial
Patent: 20002151
Estimated Expiration: ⤷ Try a Trial
Montenegro
Patent: 201
Estimated Expiration: ⤷ Try a Trial
Patent: 328
Estimated Expiration: ⤷ Try a Trial
Netherlands
Patent: 0731
Estimated Expiration: ⤷ Try a Trial
Patent: 0901
Estimated Expiration: ⤷ Try a Trial
New Zealand
Patent: 1973
Estimated Expiration: ⤷ Try a Trial
Patent: 5440
Estimated Expiration: ⤷ Try a Trial
Patent: 6645
Estimated Expiration: ⤷ Try a Trial
Patent: 5562
Estimated Expiration: ⤷ Try a Trial
Norway
Patent: 15012
Estimated Expiration: ⤷ Try a Trial
Patent: 17057
Estimated Expiration: ⤷ Try a Trial
Patent: 21039
Estimated Expiration: ⤷ Try a Trial
Peru
Patent: 110679
Estimated Expiration: ⤷ Try a Trial
Patent: 131036
Estimated Expiration: ⤷ Try a Trial
Patent: 140038
Estimated Expiration: ⤷ Try a Trial
Patent: 140835
Estimated Expiration: ⤷ Try a Trial
Patent: 141083
Estimated Expiration: ⤷ Try a Trial
Philippines
Patent: 015500289
Estimated Expiration: ⤷ Try a Trial
Poland
Patent: 68890
Estimated Expiration: ⤷ Try a Trial
Patent: 55376
Estimated Expiration: ⤷ Try a Trial
Patent: 79854
Estimated Expiration: ⤷ Try a Trial
Patent: 28481
Estimated Expiration: ⤷ Try a Trial
Patent: 92346
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
Portugal
Patent: 68890
Estimated Expiration: ⤷ Try a Trial
Patent: 55376
Estimated Expiration: ⤷ Try a Trial
Patent: 79854
Estimated Expiration: ⤷ Try a Trial
Patent: 92346
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
San Marino
Patent: 01500263
Estimated Expiration: ⤷ Try a Trial
Serbia
Patent: 854
Estimated Expiration: ⤷ Try a Trial
Patent: 856
Estimated Expiration: ⤷ Try a Trial
Patent: 282
Estimated Expiration: ⤷ Try a Trial
Patent: 619
Estimated Expiration: ⤷ Try a Trial
Patent: 790
Estimated Expiration: ⤷ Try a Trial
Patent: 982
Estimated Expiration: ⤷ Try a Trial
Singapore
Patent: 1708
Estimated Expiration: ⤷ Try a Trial
Patent: 6251
Estimated Expiration: ⤷ Try a Trial
Patent: 8951
Estimated Expiration: ⤷ Try a Trial
Patent: 201702522U
Estimated Expiration: ⤷ Try a Trial
Slovenia
Patent: 68890
Estimated Expiration: ⤷ Try a Trial
Patent: 55376
Estimated Expiration: ⤷ Try a Trial
Patent: 79854
Estimated Expiration: ⤷ Try a Trial
Patent: 28481
Estimated Expiration: ⤷ Try a Trial
Patent: 92346
Estimated Expiration: ⤷ Try a Trial
Patent: 54892
Estimated Expiration: ⤷ Try a Trial
South Africa
Patent: 1102425
Estimated Expiration: ⤷ Try a Trial
Patent: 1203502
Estimated Expiration: ⤷ Try a Trial
Patent: 1203503
Estimated Expiration: ⤷ Try a Trial
Patent: 1300112
Estimated Expiration: ⤷ Try a Trial
Patent: 1302269
Estimated Expiration: ⤷ Try a Trial
Patent: 1705519
Estimated Expiration: ⤷ Try a Trial
Patent: 1903284
Estimated Expiration: ⤷ Try a Trial
South Korea
Patent: 1452916
Estimated Expiration: ⤷ Try a Trial
Patent: 1481395
Estimated Expiration: ⤷ Try a Trial
Patent: 1586215
Estimated Expiration: ⤷ Try a Trial
Patent: 1677481
Estimated Expiration: ⤷ Try a Trial
Patent: 1831154
Estimated Expiration: ⤷ Try a Trial
Patent: 1990936
Estimated Expiration: ⤷ Try a Trial
Patent: 2059386
Estimated Expiration: ⤷ Try a Trial
Patent: 120117620
Estimated Expiration: ⤷ Try a Trial
Patent: 130053440
Estimated Expiration: ⤷ Try a Trial
Patent: 140032338
Estimated Expiration: ⤷ Try a Trial
Patent: 140037974
Estimated Expiration: ⤷ Try a Trial
Patent: 140143152
Estimated Expiration: ⤷ Try a Trial
Patent: 150008151
Estimated Expiration: ⤷ Try a Trial
Patent: 180023014
Estimated Expiration: ⤷ Try a Trial
Patent: 180026775
Estimated Expiration: ⤷ Try a Trial
Spain
Patent: 14934
Estimated Expiration: ⤷ Try a Trial
Patent: 11440
Estimated Expiration: ⤷ Try a Trial
Patent: 26908
Estimated Expiration: ⤷ Try a Trial
Patent: 46767
Estimated Expiration: ⤷ Try a Trial
Patent: 60842
Estimated Expiration: ⤷ Try a Trial
Patent: 65536
Estimated Expiration: ⤷ Try a Trial
Patent: 24246
Estimated Expiration: ⤷ Try a Trial
Patent: 91625
Estimated Expiration: ⤷ Try a Trial
Taiwan
Patent: 02070
Estimated Expiration: ⤷ Try a Trial
Patent: 19874
Estimated Expiration: ⤷ Try a Trial
Patent: 69780
Estimated Expiration: ⤷ Try a Trial
Patent: 86159
Estimated Expiration: ⤷ Try a Trial
Patent: 87700
Estimated Expiration: ⤷ Try a Trial
Patent: 86660
Estimated Expiration: ⤷ Try a Trial
Patent: 21611
Estimated Expiration: ⤷ Try a Trial
Patent: 1102063
Estimated Expiration: ⤷ Try a Trial
Patent: 1204713
Estimated Expiration: ⤷ Try a Trial
Patent: 1238948
Estimated Expiration: ⤷ Try a Trial
Patent: 1247648
Estimated Expiration: ⤷ Try a Trial
Patent: 1334778
Estimated Expiration: ⤷ Try a Trial
Patent: 1347759
Estimated Expiration: ⤷ Try a Trial
Patent: 1412707
Estimated Expiration: ⤷ Try a Trial
Patent: 1519891
Estimated Expiration: ⤷ Try a Trial
Turkey
Patent: 1815161
Estimated Expiration: ⤷ Try a Trial
Ukraine
Patent: 3052
Estimated Expiration: ⤷ Try a Trial
Patent: 5434
Estimated Expiration: ⤷ Try a Trial
Patent: 8904
Estimated Expiration: ⤷ Try a Trial
Patent: 3048
Estimated Expiration: ⤷ Try a Trial
Patent: 8080
Estimated Expiration: ⤷ Try a Trial
Uruguay
Patent: 699
Estimated Expiration: ⤷ Try a Trial
Patent: 446
Estimated Expiration: ⤷ Try a Trial
Patent: 667
Estimated Expiration: ⤷ Try a Trial
Patent: 983
Estimated Expiration: ⤷ Try a Trial
Patent: 266
Estimated Expiration: ⤷ Try a Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering TECHNIVIE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 2954892 | ⤷ Try a Trial | |
Germany | 69637976 | ⤷ Try a Trial | |
Spain | 2694073 | ⤷ Try a Trial | |
Brazil | 112013005701 | compostos antivirais | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2017040766 | ⤷ Try a Trial | |
Brazil | PI0609173 | formulação de dosagem farmacêutica sólida | ⤷ Try a Trial |
South Africa | 201200950 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TECHNIVIE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2368890 | 207 50010-2015 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIR; REGISTRATION NO/DATE: EU/1/14/982/001 20150119 |
2692346 | C201730039 | Spain | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIR O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/17/1213; DATE OF AUTHORISATION: 20170726; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1213; DATE OF FIRST AUTHORISATION IN EEA: 20170726 |
2368890 | 2015012 | Norway | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIR, ELLER ET; REG. NO/DATE: EU/1/14/982 20150120 |
2368890 | 122015000039 | Germany | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIR; REGISTRATION NO/DATE: EU/1/14/982 20150115 |
2692346 | LUC00038 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: PIBRENTASVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1213 20170728 |
2368890 | PA2015012,C2368890 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: OMBITASVIRAS; REGISTRATION NO/DATE: EU/1/14/982 20150115 |
2340029 | 122015000042 | Germany | ⤷ Try a Trial | PRODUCT NAME: PARITAPREVIR; REGISTRATION NO/DATE: EU/1/14/982 20150115 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |